Breast cancer starts when cells in breast tissue begin to grow abnormally and multiply without stopping

Breast cancer occurs when the DNA inside breast cells accumulates damage that causes them to divide uncontrollably. Unlike normal cells, which follow a set lifespan and then die, cancer cells ignore these signals and keep reproducing. Over time, these abnormal cells form a mass called a tumor. Some tumors stay in place; others develop the ability to invade nearby tissue or travel through the bloodstream and lymph system to distant parts of the body.

The breast is made of three main structures: lobules (the glands that produce milk), ducts (the tubes that carry milk to the nipple), and connective tissue that holds everything together. Cancer can start in any of these areas, though most breast cancers begin in the cells lining the ducts or lobules. Where the cancer originates determines its type and, often, how it behaves.

Key Takeaways

  • Breast cancer develops when cells in breast tissue accumulate genetic damage that causes them to multiply without stopping.
  • Most breast cancers start in the cells lining the ducts or lobules, and the location affects the cancer's type and behavior.
  • Some breast cancers are hormone-sensitive (respond to estrogen or progesterone) while others are not, which changes how they are treated.
  • Risk factors include age, family history, certain genetic mutations, hormone use, alcohol consumption, and obesity, but having a risk factor does not mean cancer will develop.

How breast cancer cells differ from normal cells

Normal breast cells have built-in brakes. They divide a set number of times, then stop and eventually die. Cancer cells ignore these signals. They divide repeatedly, resist death, and can eventually break through the tissue that normally contains them.

This happens because of mutations—changes in the genes that control cell growth and death. A single mutation rarely causes cancer. Instead, cancer usually develops after multiple mutations accumulate over years. Each mutation gives the cell a slight advantage: maybe it divides faster, or it ignores a stop signal, or it avoids being destroyed by the immune system. Over time, one cell with enough mutations outcompetes its neighbors and expands into a tumor.

Cancer cells also develop the ability to hide from the immune system and to trigger the growth of new blood vessels that feed the tumor. These capabilities distinguish cancer from benign (non-cancerous) tumors, which grow slowly and do not spread.

The main types of breast cancer

Ductal carcinoma in situ (DCIS) is cancer that has not yet broken through the wall of the duct. It is sometimes called stage 0 breast cancer because the cancer cells remain contained. DCIS is not invasive, meaning it has not spread into surrounding tissue, but it can become invasive over time if left untreated.

Invasive ductal carcinoma (IDC) is the most common type, accounting for roughly 70 to 80 percent of all breast cancers. The cancer starts in the cells lining the ducts and then breaks through the duct wall into surrounding breast tissue. From there, it can spread to lymph nodes and other parts of the body.

Invasive lobular carcinoma (ILC) starts in the lobules (milk-producing glands) and invades surrounding tissue. It accounts for about 10 to 15 percent of breast cancers. ILC can be harder to detect on mammograms than IDC because it often grows in a scattered pattern rather than forming a distinct lump.

Inflammatory breast cancer is rare but aggressive. It occurs when cancer cells block lymph vessels in the skin, causing the breast to become swollen, red, and warm. It is often diagnosed at a later stage because its symptoms resemble infection.

Hormone-sensitive breast cancer and other molecular types

Beyond location, breast cancers are classified by what receptors appear on their cell surface. These receptors determine whether the cancer cells respond to hormones or growth signals.

Hormone receptor-positive (HR+) breast cancer means the cancer cells have receptors for estrogen, progesterone, or both. These cancers grow in response to these hormones. Because of this, they can be treated with drugs that block hormone production or prevent hormones from attaching to the receptors. HR+ cancers tend to grow more slowly than other types.

HER2-positive breast cancer means the cancer cells produce excess amounts of a protein called HER2, which promotes cell growth. These cancers tend to grow faster and are more aggressive, but they respond well to drugs that target HER2 specifically.

Triple-negative breast cancer lacks receptors for estrogen, progesterone, and HER2. Because it does not respond to hormone therapy or HER2-targeted drugs, treatment options are more limited. Triple-negative cancers account for about 10 to 15 percent of breast cancers and tend to occur in younger women and in people with BRCA1 mutations.

Risk factors that increase the chance of developing breast cancer

Age is the strongest risk factor. Breast cancer is rare before age 30 and becomes more common as women age. About two-thirds of breast cancers are diagnosed in women over 55.

Family history and genetic mutations matter significantly. Women with a mother, sister, or daughter who had breast cancer have roughly double the risk. Inherited mutations in the BRCA1 or BRCA2 genes increase lifetime risk substantially—women with a BRCA1 mutation have about a 45 to 87 percent chance of developing breast cancer by age 70, depending on the specific mutation and other factors.

Hormone exposure increases risk. Women who use hormone replacement therapy during menopause, take certain birth control pills, or have never been pregnant have higher risk. Alcohol consumption, obesity (especially after menopause), and radiation to the chest before age 30 also raise risk. Having dense breast tissue—more glandular and connective tissue relative to fat—is associated with higher risk and can make cancers harder to detect on mammograms.

Having one or more risk factors does not mean cancer will develop. Many women with risk factors never get breast cancer, and some women without known risk factors do. Risk is a probability, not a certainty.

How breast cancer spreads

Breast cancer spreads through two main routes: the lymph system and the bloodstream. The lymph system is a network of vessels and nodes that drains fluid from tissues. Cancer cells can enter these vessels and lodge in nearby lymph nodes, usually under the arm. From there, they can continue spreading to distant nodes.

Cancer cells can also enter blood vessels and travel throughout the body. Common sites where breast cancer spreads include the bones, lungs, liver, and brain. When cancer spreads to a distant site, it is called metastatic breast cancer or stage 4 breast cancer. The cancer cells at the new site are still breast cancer cells—they retain the characteristics of the original tumor—even though they are now in a different organ.

The stage of breast cancer (0 through 4) reflects how far it has spread and helps determine treatment options and prognosis. Early-stage cancers that have not spread beyond the breast or nearby lymph nodes generally have better outcomes than cancers that have metastasized.

Why some people develop breast cancer and others do not

Breast cancer results from a combination of genetic damage and chance. Some of that damage is inherited—passed down through families in genes like BRCA1 and BRCA2. But most breast cancer is not hereditary. Instead, the genetic mutations that cause it develop over a person's lifetime due to exposure to risk factors, aging, and random cellular errors that accumulate.

This is why breast cancer is sometimes described as a disease of aging. The longer cells divide, the more opportunities mutations have to occur. A 30-year-old woman has had fewer cell divisions in her breast tissue than a 60-year-old, so she has had fewer chances for the multiple mutations needed to cause cancer.

Researchers continue to study why some people with risk factors develop cancer while others do not. Factors like immune function, the body's ability to repair DNA damage, and interactions between multiple genes all play a role. This is an active area of research, and our understanding continues to evolve.

Frequently Asked Questions

Is breast cancer always a lump?

No. While a lump is the most common sign, breast cancer can also appear as thickening, dimpling, redness, nipple discharge, or changes in breast shape or size. Some cancers, especially invasive lobular carcinoma, grow in scattered patterns and may not form a distinct lump at all. This is one reason mammography and clinical exams are important—they can detect changes that a person might not feel.

Can men get breast cancer?

Yes, though it is rare. Men have breast tissue, and cancer can develop in it. Male breast cancer accounts for less than 1 percent of all breast cancers. Men often have higher risk if they have a family history of breast cancer, carry a BRCA mutation, have liver disease, or have been exposed to radiation. Because men are less likely to suspect breast cancer, it is sometimes diagnosed at a later stage.

Does having dense breast tissue mean I will get cancer?

No. Dense breast tissue is a risk factor, meaning it is associated with higher risk, but it does not cause cancer. Dense tissue also makes it harder for mammograms to detect cancer, so women with dense breasts may benefit from additional screening methods like ultrasound or MRI. Your doctor can tell you whether your breasts are dense based on your mammogram report.

If my mother had breast cancer, will I definitely get it?

No. Having a family history increases risk, but it does not may provide cancer will develop. The lifetime risk for a woman whose mother had breast cancer is roughly double that of a woman with no family history, but most women with a family history do not develop breast cancer. Genetic testing can clarify your individual risk if you have a strong family history.

What is the difference between breast cancer and a benign breast tumor?

Benign tumors grow slowly, do not invade surrounding tissue, and do not spread to other parts of the body. Breast cancer cells divide rapidly, can break through tissue boundaries, and have the potential to metastasize. A biopsy—a sample of tissue examined under a microscope—is the only way to know for certain whether a tumor is benign or cancerous.